Dr. Tang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1190 5th Ave
New York, NY 10029Phone+1 212-659-6800Fax+1 212-659-6818
Education & Training
- University of Toronto Faculty of MedicineClass of 2002
Certifications & Licensure
- FL State Medical License 2020 - Present
- CA State Medical License 2012 - 2026
- PA State Medical License 2012 - 2026
- NY State Medical License 2011 - 2025
Publications & Presentations
PubMed
- Two-year Outcomes of Transcatheter Edge-to-edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Trial.Saibal Kar, Raj R Makkar, Brian K Whisenant, Nadira Hamid, Hursh Naik
Circulation. 2025-03-30 - 2 citations1-Year Real-World Outcomes of TAVR With the Fifth-Generation Balloon-Expandable Valve in the United States.Annapoorna S Kini, Gilbert H L Tang, Ricardo Yaryura, George Petrossian, David K Roberts
JACC. Cardiovascular Interventions. 2025-03-24 - Dynamic Tricuspid Regurgitation in Acute Heart Failure: A Prognostic Challenge and Therapeutic Opportunity.Bhavanadhar Penta, Gilbert H L Tang
Journal of Cardiac Failure. 2025-03-22
Lectures
- Impact of Initial Evolut TAVR Deployment Orientation on Final Valve Orientation and Coronary Reaccess: A Pilot StudyCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
- Neochord Transapical: Technology, FDA Pivotal Trial Updates (RECHORD), Progress With Transseptal VersionCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/14/2019
- Does Orienting Sapien 3 During Crimping in TAVR Affect Final Orientation to Coronaries to Impact TAV-in-TAV and Coronary Reaccess? A Pilot StudyCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
- Join now to see all
Press Mentions
- By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATEMarch 31st, 2025
- New Transcatheter Tricuspid Treatment Options Poised to Drive Surgical Volume GrowthJanuary 28th, 2025
- Top Structural Heart News of 2024December 29th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: